Transcutaneous Electroacupuncture for Gastric Complications of Scleroderma

Completed · Not applicable

Conditions studied: Scleroderma, Gastroparesis

In brief

An innovative method of needleless transcutaneous electroacupuncture (TEA) using a newly developed watch-size stimulator is proposed. Weak electrical current will be delivered via skin surface electrodes to acupuncture points related to gastrointestinal functions. The stimulator can be attached to the skin near the acupuncture points and therefore daily activity of the patient does not need to be altered. Two experiments are designed to prove the feasibility of the proposed therapy for gastric complications of Scleroderma .

Key facts

Study ID

NCT03294616

Run by

Johns Hopkins University

People needed

23

Starts

2017-02-06

Expected to finish

2019-11-20

Last updated by the study team

2019-11-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No any systemic diseases;
• no scleroderma; no history of gastrointestinal surgery;
• no dyspeptic symptoms during the past 2 weeks;
• not taking any medications except contraceptives during the past 2 weeks;
• age 18 and older.

You may not qualify if…

• History of any systemic diseases or surgeries;
• allergic to adhesives; pregnancy;
• unable to sign the consent form.

Where it is running

• Johns Hopkins Bayview Medical Center — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.